The intensity of the immune response to cancer is determined by the genes of each patient, according to researchers in the Department of Molecular and Cellular Biology at Roswell Park Cancer Institute. This finding will contribute to the early assessment of prognosis of patients and an individualized choice of optimal therapy. [click link for full article]